CORAL SPRINGS, Fla. - May 28, 2026 - In response to the recent presidential executive order accelerating the review and availability of psychedelic medicines, Ibogaine by David Dardashti today announced a comprehensive new initiative. The organization aims to educate the public and state lawmakers on its fully integrated ibogaine safety protocols, while simultaneously expanding its advocacy footprint and global partnerships to ensure a sustainable, ethical supply chain.
The sweeping executive order, which includes a historic $50 million federal commitment and directs the FDA and DEA to facilitate patient access under the Right to Try Act, has triggered widespread legislative action. With states like Texas securing major investments for FDA-supervised trials and over fifteen others exploring similar frameworks, the political walls surrounding ibogaine treatment are rapidly coming down.
As domestic availability nears, Ibogaine by David Dardashti is stepping forward to share the clinical blueprint it has perfected over years of successful treatments.
“Patient safety has always been our absolute highest priority,” said a spokesperson for the clinic. “Because ibogaine interacts with the heart, it requires rigorous oversight. We are opening our doors and our empirical data to lawmakers to demonstrate exactly how our protocols safely manage this powerful medicine.”
This focused educational push will highlight the clinic’s integrated cardiac monitoring systems, precise dosing algorithms utilizing supplemental magnesium, and proven long-term efficacy data to help shape a safe national standard of care.
In addition to sharing its clinical expertise, the clinic announced its active support and financial contributions to Americans for Ibogaine. Founded by dedicated advocates, this national coalition is leading the charge to reduce public stigma and build the necessary infrastructure for legal, accessible ibogaine treatment across the United States.
Finally, as the demand for ibogaine skyrockets, the clinic is addressing the critical need for global sustainability. Closely monitoring the upcoming ibogaine convention in Gabon, Ibogaine by David Dardashti seeks to deepen its relationship with the Bwiti tribe and the Gabonese government. The ultimate goal is to ensure that advancing political availability in the U.S. relies on an ethical supply chain that directly protects and benefits the indigenous communities who have guarded this medicine for centuries.
For more information regarding our protocols, please visit www.ibogaineclinic.com
About Ibogaine by David Dardashti:
Ibogaine by David Dardashti is a premier treatment and research facility dedicated to overcoming addiction and trauma through safe, scientifically grounded therapies. The clinic utilizes advanced cardiac monitoring and individualized dosing protocols to safely ensure optimal patient recovery.
Media Contact
Company Name: Ibogaine By David Dardashti
Contact Person: Cole Barressi
Email: Send Email
Country: United States
Website: www.ibogaineclinic.com
